MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 3Y Ago
-1.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -59.10% |
| 2023 | -32.99% |
| 2022 | 65.51% |
| 2021 | 46.87% |
| 2020 | -51.62% |
| 2019 | 0.00% |